(Q43981468)

28 November 2017

title

Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56(Lck). (English)

1 reference

28 November 2017

Ping Chen

1

1 reference

28 November 2017

Derek Norris

2

1 reference

28 November 2017

Edwin J Iwanowicz

3

1 reference

28 November 2017

Steven H Spergel

4

1 reference

28 November 2017

James Lin

5

1 reference

28 November 2017

Henry H Gu

6

1 reference

28 November 2017

Zhongqi Shen

7

1 reference

28 November 2017

John Wityak

8

1 reference

28 November 2017

Tai-An Lin

9

1 reference

28 November 2017

Suhong Pang

10

1 reference

28 November 2017

Henry F De Fex

11

1 reference

28 November 2017

Sidney Pitt

12

1 reference

28 November 2017

Ding Ren Shen

13

1 reference

28 November 2017

Arthur M Doweyko

14

1 reference

28 November 2017

Donna A Bassolino

15

1 reference

28 November 2017

Jacques Y Roberge

16

1 reference

28 November 2017

Michael A Poss

17

1 reference

28 November 2017

Bang-Chi Chen

18

1 reference

28 November 2017

Gary L Schieven

19

1 reference

28 November 2017

Joel C Barrish

20

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

28 November 2017

published in

1 reference

28 November 2017

volume

12

1 reference

28 November 2017

issue

10

1 reference

28 November 2017

page(s)

1361-1364

1 reference

Profound block in thymocyte development in mice lacking p56lck

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Signal transduction by lymphocyte antigen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

1-Methoxy-agroclavine from Penicillium sp. WC75209, a novel inhibitor of the Lck tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

The development of novel and selective p56lck tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

SH2-directed ligands of the Lck tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Ligands for the Tyrosine Kinase p56lckSH2 Domain: Discovery of Potent Dipeptide Derivatives with Monocharged, Nonhydrolyzable Phosphate Replacements

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900191-9

7 January 2021

10.1016/S0960-894X(02)00191-9

Identifiers

DOI

1 reference

28 November 2017

1 reference